Ligand-induced rapid skeletal muscle atrophy in HSA-Fv2E-PERK transgenic mice
暂无分享,去创建一个
H. Kiyonari | H. Sakaue | M. Miyake | S. Oyadomari | K. Takehana | M. Morimoto | Jun Zhang | Masashi Kuroda | Miho Oyadomari | S. Hisanaga
[1] S. Welle,et al. The Regulation of Skeletal Muscle Protein Turnover During the Progression of Cancer Cachexia in the Apc Min / + Mouse , 2019 .
[2] Guangyu Jiao,et al. Upregulation of endoplasmic reticulum stress is associated with diaphragm contractile dysfunction in a rat model of sepsis. , 2017, Molecular medicine reports.
[3] Ashok Kumar,et al. Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] D. Ron,et al. Skeletal muscle–specific eukaryotic translation initiation factor 2α phosphorylation controls amino acid metabolism and fibroblast growth factor 21–mediated non–cell-autonomous energy metabolism , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] J. Klein-Nulend,et al. Aging related ER stress is not responsible for anabolic resistance in mouse skeletal muscle. , 2015, Biochemical and biophysical research communications.
[6] G. Schuler,et al. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training , 2015, Journal of cachexia, sarcopenia and muscle.
[7] J. Pessin,et al. Skeletal muscle autophagy: a new metabolic regulator , 2013, Trends in Endocrinology & Metabolism.
[8] S. Kimball,et al. Regulation of muscle protein synthesis and the effects of catabolic states. , 2013, The international journal of biochemistry & cell biology.
[9] Steven D. Kunkel,et al. Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. , 2013, American journal of physiology. Endocrinology and metabolism.
[10] M. Sandri,et al. Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.
[11] N. Sonenberg,et al. Principles of translational control: an overview. , 2012, Cold Spring Harbor perspectives in biology.
[12] Jon R Lorsch,et al. The mechanism of eukaryotic translation initiation: new insights and challenges. , 2012, Cold Spring Harbor perspectives in biology.
[13] Steven D. Kunkel,et al. Stress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy* , 2012, The Journal of Biological Chemistry.
[14] B. Saltin,et al. GLUT4 and Glycogen Synthase Are Key Players in Bed Rest–Induced Insulin Resistance , 2012, Diabetes.
[15] S. Welle,et al. The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse , 2011, PloS one.
[16] P. Greenhaff,et al. Novel events in the molecular regulation of muscle mass in critically ill patients , 2011, The Journal of physiology.
[17] B. Spiegelman,et al. The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex. , 2011, Cell metabolism.
[18] C. Zechner,et al. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. , 2010, Cell metabolism.
[19] T. van Groen,et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. , 2010, The Journal of clinical investigation.
[20] G. Schuler,et al. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training , 2010, Journal of cachexia, sarcopenia and muscle.
[21] D. Lacey,et al. Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.
[22] L. Schaeffer,et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy , 2009, The Journal of cell biology.
[23] S. Bodine,et al. Age-related deficit in load-induced skeletal muscle growth. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[24] E. Casanova,et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.
[25] D. Ron,et al. Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. , 2008, Cell metabolism.
[26] B. Spiegelman,et al. Skeletal Muscle Fiber-type Switching, Exercise Intolerance, and Myopathy in PGC-1α Muscle-specific Knock-out Animals* , 2007, Journal of Biological Chemistry.
[27] S. Sakoda,et al. Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle , 2007, Acta Neuropathologica.
[28] M. Katze,et al. Cotranslocational Degradation Protects the Stressed Endoplasmic Reticulum from Protein Overload , 2006, Cell.
[29] M. Katze,et al. Cotranslocational Degradation Protects the Stressed Endoplasmic Reticulum from Protein Overload , 2006, Cell.
[30] S. Kandarian,et al. The molecular basis of skeletal muscle atrophy. , 2004, American journal of physiology. Cell physiology.
[31] R. Wolfe,et al. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. , 2003, The American journal of clinical nutrition.
[32] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[33] D. Ron,et al. Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.
[34] S. R. Datta,et al. DNA Repair Pathway Stimulated by the Forkhead Transcription Factor FOXO3a Through the Gadd45 Protein , 2002, Science.
[35] C. Gregorio,et al. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.
[36] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] G. Yancopoulos,et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.
[38] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[39] A. Goldberg,et al. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.
[40] S. Kimball,et al. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. , 2000, The Journal of nutrition.
[41] T. Soga,et al. Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. , 2000, Analytical chemistry.
[42] S. Kimball,et al. Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation. , 2000, The Journal of nutrition.
[43] A. Goldberg,et al. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.
[44] S. Kimball,et al. Implication of eIF2B Rather Than eIF4E in the Regulation of Global Protein Synthesis by Amino Acids in L6 Myoblasts* , 1998, The Journal of Biological Chemistry.
[45] N. Forsberg,et al. Role of calpain in skeletal-muscle protein degradation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Welsh,et al. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin , 1998, FEBS letters.
[47] G. Biolo,et al. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. , 1997, The American journal of physiology.
[48] P. Ponikowski,et al. Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.